Meyka Pro is live. Get 50% off your first 3 months.Get Started →
Cellebrite DI Ltd.

Cellebrite DI Ltd. (CLBT) Stock Overview

Explore Cellebrite DI Ltd.’s financial performance, market position, analyst ratings, and future outlook.

CLBT●NASDAQ
TechnologySoftware - Infrastructure
$15.61
$0.57(3.52%)
U.S. Market is Open · 09:52

Cellebrite DI Ltd. (CLBT)

Meyka AI Score

Z

Key Financials

Market Cap3.9B
P/E Ratio53.91
EPS (TTM)$0.39
ROE0.16%
Fundamental Analysis

AI Price Forecasts

1 Month$13.94
3 Months$13.81
1 Year Target$12.87

CLBT Stock Analysis & Investment Overview

Our comprehensive AI-powered analysis of Cellebrite DI Ltd. (CLBT) provides investors with deep insights into the stock's performance, growth potential, and market positioning. With a Meyka AI Score of B+, this stock demonstrates moderate investment characteristics based on our advanced machine learning models.

The current technical analysis reveals key indicators including an RSI of 62.26, suggesting the stock is in a neutral condition. Our forecasting models predict significant price movements, with a 12-month target of $12.87.

Key financial metrics showcase the company's fundamental strength, including a P/E ratio of 53.91 and a market capitalization of 3.9B. These metrics, combined with our AI analysis, provide a comprehensive view for both institutional and retail investors.

1-Day Change
-2.16%
5-Day Change
-3.89%
1-Month Change
21.30%
3-Month Change
26.54%
6-Month Change
-9.08%
Year-to-Date (YTD) Change
-12.20%
1-Year Change
11.09%
3-Year Change
120.47%
5-Year Change
58.78%
All-Time (Max) Change
63.87%

Contact Information

https://www.cellebrite.com
972 73 394 8000
94 Shlomo Shmelzer Road, Petah Tikva, HM, 4970602

Company Facts

11,670 Employees
IPO DateNov 6, 2020
CountryIL
Actively Trading

Frequently Asked Questions